362707-88-8

Basic information

• Product Name: 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid methyl ester
• Synonyms: 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid methyl ester
• CAS NO: 362707-88-8
• Molecular Weight: 407.51
• Mol File: 362707-88-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid methyl ester(362707-88-8)
• EPA Substance Registry System: 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid methyl ester(362707-88-8)

Safety Data

• Hazardous Substances Data: 362707-88-8(Hazardous Substances Data)

Upstream product

• 363185-22-2 7-ethoxy-2,3-dihydro-2,2-dimethyl-5-(2-methyl-1-propenyl)benzofuran 
• 1129-35-7 4-cyanobenzoic acid methyl ester 

Downstream Products

• 362708-44-9 4-(6-ethoxy-3,4,8,9-tetrahydro-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)benzoic acid hydrochloride 

Relevant articles and documents

FUROISOQUINOLINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF

A compound having a partial structure represented by Formula: or a salt thereof has an excellent phosphodiesterase (PDE) IV-inhibiting effect, and is useful as a prophylactic or therapeutic agent against inflammatory diseases, for example, bronchial asthma, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, autoimmune disease, diabetes and the like.